Paper Details

  1. Home
  2. Paper Details

Efficacy of diflunisal versus naproxen in osteoarthritis of the knee: an open study.

Author: DealC L, MoskowitzR W

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.

Overview

Both diflunisal and naproxen were effective in treating osteoarthritis of the knee and were well tolerated.
Paper Details　
Original Abstract of the Article :
Thirty-one patients with osteoarthritis of the knee were treated with either diflunisal (n = 17) or naproxen (n = 14) in a 12-week open-label study. Treatment was begun with 500 mg BID of diflunisal or 375 mg BID of naproxen. Patients not showing an adequate response to these dosages were given incr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3548982

データ提供：米国国立医学図書館（NLM）

Comparing Diflunisal and Naproxen for Knee Osteoarthritis

The world of osteoarthritis is a challenging one. Many individuals struggle with persistent pain and stiffness, impacting their daily lives. This study aims to help patients navigate these challenges by comparing two common medications: diflunisal and naproxen. Like a diligent explorer mapping out a vast, unfamiliar landscape, the researchers conducted an open-label study to assess the effectiveness of these drugs in treating knee osteoarthritis. They carefully observed 31 patients over 12 weeks, recording their responses to each medication. The results provide valuable insights into the comparative efficacy and safety of these two options.

Both Medications Show Promise, But No Clear Winner

Both diflunisal and naproxen demonstrated statistically significant improvements in various pain indices, tenderness, swelling, and functional capacity. While both drugs proved effective, there was no significant difference found between them. This suggests that patients and their doctors have a degree of flexibility in choosing one medication over the other, based on individual preferences and potential side effects.

Navigating the Desert of Pain Relief

This study provides valuable information for individuals seeking relief from knee osteoarthritis. While both medications appear to offer similar benefits, it's essential to consult with your healthcare provider to determine the best course of treatment. It's also important to be aware of potential side effects, as even the most promising medications can have unwanted consequences. Remember, navigating the desert of pain relief requires a trusted guide, and your doctor is your most valuable resource.

Dr. Camel's Conclusion

This study is a reminder that the journey towards pain relief can be complex and often involves a search for the right fit. Both diflunisal and naproxen appear to be viable options for treating knee osteoarthritis. Remember, your doctor is your trusted companion, helping you navigate the desert of pain and find the oasis of relief.

Date :
  1. Date Completed 1987-04-27
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

3548982

DOI: Digital Object Identifier

3548982

Related Literature

Article Analysis
・Side Effects of diflunisal
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.